Commit Biologics ("Commit"), today announced positive results from a non-human primate (NHP) study demonstrating proof-of-concept for its proprietary Complement Engager (BiCE™) platform. The study ...

A longevity expert reveals how immune systems begin aging after 35, making people more susceptible to infections and immune-related disorders over time.

Single subcutaneous dose of ADX-038 achieved near-complete alternative pathway suppression for 6 months, supporting potent and selective CFB ...

Dr Manav Manchanda explains whether air purifiers can really prevent pneumonia and how they help support lung health during ...

Packed with vitamins, antioxidants, and natural healing ingredients, these tiny shots can help strengthen your body’s defense system.

Blocking the mechanism that cancer cells exploit to avoid destruction by the immune system could spur new treatments for the ...

Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare Disease portfolio Omeros is eligible to receive 340 million US dollars in ...

A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...

Apellis Pharmaceuticals (NASDAQ: APLS) is preparing to release its quarterly earnings on Thursday, 2025-10-30. Here's a brief overview of what investors should keep in mind before the announcement.

Livestock producers looking for a less expensive winter supplement this year should consider alfalfa for its nutritional ...

Glioblastoma is an aggressive brain cancer that almost always recurs after surgery and radiochemotherapy. Now, researchers ...